Mitochondria and cancer

Mitochondria and Cancer

Volumn , Issue , 2009, Pages 1-21

  Owens, Kjerstin M ^a   Modica Napolitano, J S ^a   Singh, Keshav K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68149099559     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-84835-8_1     Document Type: Chapter

References (144)

1. Aebi, H. 1984. Catalase in vitro. Methods Enzymol. 105:121-126
2. Aufderheide, K. J. 1980. Mitochondrial associations with specific microtubular components of the cortex of Tetrahymena thermophila. II. Response of the mitochondrial pattern to changes in the microtubule pattern. J. Cell. Sci. 142:247-260
3. Beurdeley-Thomas, A., Miccoli, L., Oudard, S., Dutrillaux, B., and Poupon, M. F. 2000. The peripheral benzodiazepine receptors: A review. J. Neurooncol. 46:45-56
4. Bianchi, N. O., Bianchi, M. S., Richard, S. M. 2001. Mitochondrial genome instability in human cancers. Mutat. Res. 488:9-23
5. Boddapati, S. V., Tongcharoensirikul, P., Hanson, R. N., D'Souza, G. G., Torchilin, V. P., Weissig, V. 2005. Mitochondriotropic liposomes. J. Liposome Res. 15:49-58
6. Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., Harry, G., Hashimoto, K., Porter, C. J., Andrade, M. A., Thebaud, B., Michelakis, E. D. 2007. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 11:37-51
7. Borutaite, V., Budriunaite, A., and Brown, G. C. 2000. Reversal of nitric oxide-, peroxynitrite- and S-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. Biochim. Biophys. Acta 1459:405-412
8. Boveris, A., and Chance, B. 1973. The mitochondrial generation of hydrogen peroxide. Biochem. J. 134:707-716
9. Brand, M. D., Affouritt, C., Esteves, T. C., Green, K., Lambert, A. J., Miwa, S., Pakay, J. L., and Parker, N. 2004. Free Radic. Biol. Med. 37:755-767
10. Brimmell, M., Mendiola, R., Mangion, J., and Packham, G. 1998. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16:1803-1812
11. Brookes, P. S., and Darley-Usmar, V. M. 2002. Hypothesis: The mitochondrial NO signalling pathway, and the transduction from nitrosative to oxidative cell signals: An alternative function for cytochrome c oxidase. Free Radic. Biol. Med. 32:370-374
12. Burwell, L. S., Nadtochiy, S. M., Tompkins, A. J., Young, S., and Brookes, P. S. 2006. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 394:627-634
13. Campbell, A. M., and Chan, S. H. P. 2007. The voltage dependent anion channel affects mitochondrial cholesterol distribution and function. Arch. Biochem. Biophys. 466:203-210
14. Canter, J. A., Kallianpur, A. R., Parl, F. F., Millikan, R. C. 2005. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65:8028-8033
15. Capuano, F., Guerrieri, F., and Papa, S. 1997. Oxidative phosphorylation enzymes in normal and neoplastic cell growth. J. Bioenerg. Biomembr. 29:379-384
16. Capuano, F., Varone, D., D'Eri, N., Russo, E., Tommasi, S., Montemurro, S., Prete, F., and Papa, S. 1996. Oxidative phosphorylation and F (0) F (1) ATP synthase activity of human hepatocellular carcinoma. Biochem. Mol. Biol. Int. 38:1013-1022
17. Carafoli, E. 1980. Mitochondria and disease. Molec. Aspects Med. 3:295-429
18. Cejas, P., Casado, E., Belda-Iniesta, C., De Castro, J., Espinosa, E., Redondo, A., Sereno, M., Garcia-Cabezas, M. A., Vara, J. A. F., Domingues-Caceres, A., Rosario, P., and Gonzalez-Baron, M. 2004. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer. Cancer Causes Control 15:707-719
19. Chan, S. H., and Barbour, R. L. 1983. Adenine nucleotide transport in hepatoma mitochondria. Characterization of factors influencing the kinetics of ADP and ATP uptake. Biochim. Biophys. Acta 723:104-113
20. Chatterjee, A., Mambo, E., Sidransky, D. 2006. Mitochondrial DNA mutations in human cancer. Oncogene 25:4663-4674
21. Chen, Y. R., Chen, C. L., Pfeiffer, D. R., and Zweier, J. L. 2007a. Mitochondrial complex II in the post-ischemic heart: Oxidative injury and the role of protein S-glutathionylation. J. Biol. Chem. 282:32640-32654
22. Chen, C. L., Zhang, L., Yeh, A., Chen, C. A., Green-Church, K. B., Zweier, J. L., and Chen, Y. R. 2007b. Site-specific S-glutathiolation of mitochondrial NADH ubiquinone reductase. Biochemistry 46:5754-5765
23. Christians, F. C., Newcomb, T. G., and Loeb, L. A. 1995. Potential sources of multiple mutations in human cancers. Prev. Med. 24:329-332
24. Chu, F. F., Doroshow, J. H., and Esworthy, R. S. 1993. J. Biol. Chem. 4:2571-2576
25. Chu, F. F., Esworthy, R. S., and Doroshow, J. H. 2004. Free Radic. Biol. Med. 36:1481-1495
26. Clayton, D. A., and Vinograd, J. 1969. Complex mitochondrial DNA in leukemic and normal human myeloid cells. Proc. Natl. Acad. Sci. USA. 62:1077-1084
27. Cleeter, M. W. J., Cooper, J. M., Darley-Usmar, V. M., Moncada, S., and Schapira, A. H. V. 1994. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. FEBS Lett. 345:50-54
28. Clementi, E., Brown, G. C., Feelish, M., and Moncada, S. 1998. Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Nat. Acad. Sci. USA 95:7631-7636
29. Covello, K. L., and Simon, M. C. 2004. HIFs, hypoxia, and vascular development. Curr. Topics Dev. Biol. 62:37-54
30. Coleman, M. C., Asbury, C. R., Daniels, D., Du, J., Aykin-Burns, N., Smith, B. J., Li, L., Spitz, D. R., Cullen, J. J. 2008. 2-Deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Free Radic. Biol. Med. 44:322-331
31. Costantini, P., Jacotot, E., Decaudin, D., Kroemer, G. 2000. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst. 92:1042-1053
32. Cuezva, J. M., Ostronoff, L. K., Ricart, J., López de Heredia, M., Di Liegro, C. M., and Izquierdo, J. M. 1997. Mitochondrial biogenesis in the liver during development and oncogenesis. J. Bioenerg. Biomembr. 29:365-377
33. Dakubo, G. D., Parr, R. L., Costello, L. C., Franklin, R. B., Thayer, R. E. 2006. Altered metabolism and mitochondrial genome in prostate cancer. J. Clin. Pathol. 59:10-16
34. De Marzo, A. M., Marchi, V. L., Epstein, J. I., Nelson, W. G. 1999. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am. J. Pathol. 155:1985-1992
35. Desouki, M. M., Kulawiec, M., Bansal, S., Das, G. M., Singh, K. K. 2005. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol. Ther. 4:1367-1373
36. Dougherty, T. J., Weishaupt, K. R., and Boyle, D. G. 1985. Photodynamic Sensitizers. J. B. Lipincott, Philadelphia, PA, USA
37. Douwes Dekker, P. B., Hogendoorn, P. C. W., Kuipers-Dijkshoorn, N., Prins, F. A., van Duinen, S. G., Taschner, P. E. M., van der Mey, A. G. L., and Cornelisse, C. J. 2003. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J. Path. 201:480-486
38. D'Souza, G. G., Boddapati, S. V., Weissig, V. 2005. Mitochondrial leader sequence-Plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria. Mitochondrion 5:352-358
39. Emerit, I. 1994. Reactive oxygen species, chromosome mutation, and cancer: Possible role of clastogensic factors in carcinogenesis. Free Radic. Biol. Med. 16:99-109
40. Faure Vigny, H., Heddi, A., Giraud, S., Chautard, D., and Stepien, G. 1996. Expression of oxidative phosphorylation genes in renal tumors and tumoral cell lines. Mol. Carcinog. 16:165-172
41. Fliss, M. S., Usadel, H., Caballero, O. L., Wu, L., Buta, M. R., Eleff, S. M., Jen, J., Sidransky, D. 2000. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019
42. Freedland, S. J., Mavropoulos, J., Wang, A., Darshan, M., Demark-Wahnefried, W., Aronson, W. J., Cohen, P., Hwang, D., Peterson, B., Fields, T., Pizzo, S. V., Isaacs, W. B. 2008. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68:11-19
43. Galiegue, S., Jbilo, O., Combes, T., Bribes, E., Carayon, P., Le Fur, G., and Casellas, P. 1999. Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J. Biol. Chem. 274:2938-2952
44. Gao, N., Ding, M., Zheng, J. Z., Zhang, Z., Leonard, S. S., Liu, K. J., Shi, X., Jiang, B. H. 2002. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277:31963-31971
45. Gibson, B. W. 2005. The human mitochondrial proteome: Oxidative stress, protein modifications and oxidative phosphorylation. Int. J. Biochem. Cell Biol. 37:927-934
46. Gimenez-Roqueplo, A. P., Favier, J., Rustin, P., Mourad, J. J., Plouin, P. F., Corvol, P., Rotig, A., and Jeunemaitre, X. 2001. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activiy of Complex II in the mitochondrial respiratory chain and activities the hypoxia pathway. Am. J. Hum. Genet. 69:1186-1197
47. Giraud, S., Bonod-Bidaud, C., Wesolowski-Louvel, M., and Stepien, G. 1998. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J. Mol. Biol. 281:409-418
48. Grossman, L. I., and Shoubridge, E. A. 1996. Mitochondrial genetics and human disease. Bioessays 18:983-991
49. Heerdt, B. G., Halsey, H. K., Lipkin, M., and Augenlicht, L. H. 1990. Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer. Cancer Res. 50:1596-1600
50. Herrmann, P. C., Gillespie, J. W., Charboneau, L., Bischel, V. E., Paweletz, C. P., Calvert, V. S., Kohn, E. C., Emmert-Buck, M. R., Liotta, L. A., and Petricoin, E. F. 2003. Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 3:1801-1810
51. Ishii, T., Yasuda, K., Akatsuka, A., Hino, O., Hartman, P. S., and Ishii, N. 2005. A mutation in the SDHC gene of Complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res. 65:203-209
52. Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., Hayashi, J. 2008. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 320:661-664
53. Jackson, A. L., and Loeb, L. A. 2001. The contribution of endogenous sources of DNA damage to the mutliple mutations in cancer. Mutat. Res. 477:7-21
54. Jakupciak, J. P., Wang, W., Markowitz, M. E., Ally, D., Coble, M., Srivastava, S., Maitra, A., Barker, P. E., Sidransky, D., O'Connell, C. D. 2005. Mitochondrial DNA as a cancer biomarker. J Mol. Diagn. 7:258-267
55. Jazayeri, M., Andreyev, A., Will, Y., Ward, M., Anderson, C. M., Clevenger, W. 2003. Inducible expression of a dominant negative DNA polymerase-gamma depletes mitochondrial DNA and produces a rho0 phenotype. J. Biol. Chem. 278:9823-9830
56. Jiang, W. W., Masayesva, B., Zahurak, M., Carvalho, A. L., Rosenbaum, E., Mambo, E., Zhou, S., Minhas, K., Benoit, N., Westra, W. H., Alberg, A., Sidransky, D., Koch, W., Califano, J. 2005. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res 11:2486-2491
57. Johns, D. R. 1995. Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. New Engl. J. Med. 333:638-644
58. Johnson, L. V., Walsh, M. L., Bockus, B. J., Chen, L. B. 1981. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell Biol. 88:526-535
59. Klein, E. A., Lipman, S. M., Thompson, I. M., Goddman, P. J., Albanes, D., Taylor, P. R., and Coltman, C. 2003. World J. Urol. 21:21-27
60. Kono, Y., and Fridovich, I. 1982. Superoxide radical inhibits catalase. J. Biol. Chem. 257:5751-5754
61. Kowaltowski, A. L., and Vercesi, A. E. 1998. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 26:463-471
62. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620
63. Kroemer, G., Galluzzi, L., and Brenner, C. 2007. Mitochondrial membrane permealization in cell death. Physiol. Rev. 87:99-163
64. Kulawiec, M., Safina, A., Dosouki, M., Matsi, I., Bakin, A., and Singh, K. K. 2008. Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. Cancer Biol. Therapy. 263:4450-4459
65. Lee, H. C., Yin, P. H., Lin, J. C., Wu, C. C., Chen, C. Y., Wu, C. W., Chi, C. W., Tam, T. N., Wei, Y. H. 2005. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann. NY Acad. Sci. 1042:109-122
66. Lewis, W., Day, B. J., Kohler, J. J., Hosseini, S. H., Chan, S. S., Green, E. C., Haase, C. P., Keebaugh, E. S., Long, R., Ludaway, T., Russ, R., Steltzer, J., Tioleco, N., Santoianni, R., Copeland, W. C. 2007. Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase gamma. Lab Invest. 87:326-335
67. Lin, X., Zhang, F., Bradbury, C. M., Kaushal, A., Li, L., Spitz, D. R., Aft, R. L., Gius, D. 2003. 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res. 63:3413-3417
68. Lievre, A., Chapusot, C., Bouvier, A. M., Zinzindohoue, F., Piard, F., Roignot, P., Arnould, L., Beaune, P., Faivre, J., Laurent-Puig, P. 2005. Clinical value of mitochondrial mutations in colorectal cancer. J. Clin. Oncol. 23:3517-3525
69. Liu, C. S., Tsai, C. S., Kuo, C. L., Chen, H. W., Lii, C. K., Ma, Y. S., and Wei, Y. H. 2003. Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic. Res. 37:307-1317
70. Luciakova, K., and Kuzela, S. 1992. Increased steady-state levels of several mitochondrial and nuclear gene transcripts in rat hepatoma with a low content of mitochondria. Eur. J. Biochem. 205:1187-1193
71. Mambo, E., Chatterjee, A., Xing, M., Tallini, G., Haugen, B. R., Yeung, S. C., Sukumar, S., Sidransky, D. 2005. Tumor-specific changes in mtDNA content in human cancer. Int. J. Cancer 116:920-924
72. Marnett, L. J. 1999. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 424:83
73. Martinez-Cayuela, M. 1995. Oxygen free radicals and human disease. Biochimie 77:47-161
74. Matoba, S., Kang, J. G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., Hwang, P. M. 2006. p53 regulates mitochondrial respiration. Science 312:1650-1653
75. McCord, J. M., and Fridovich, I. 1969. An enzymtic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049-6055
76. Mitchell, P. 1961. Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism. Nature 191:144-148
77. Modica-Napolitano, J. S., and Aprille, J. R. 1987. Basis for the selective cytotoxicity of rhodamine 123. Cancer Res. 47:4361-4365
78. Modica-Napolitano, J. S., Joyal, J. L., Ara, G., Oseroff, A. R., Aprille, J. R. 1990. Mitochondrial toxicity of cationic photosensitizers for photochemotherapy. Cancer Res. 50:7876-7881
79. Modica-Napolitano, J. S., Koya, K., Weisberg, E., Brunelli, B. T., Li, Y., Chen, L. B. 1996. Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. Cancer Res. 56:544-550
80. Modica-Napolitano, J. S., Kulawiec, M., and Singh, K. K. 2007. Mitochondria and human cancer. Curr. Molec. Med. 7:1-11
81. Modica-Napolitano, J. S., and Touma, S. E. 2000. Functional differences in mitochondrial enzymes from normal epithelial and carcinoma cells. In Mitochondrial Dysfunction in Pathogenesis, A Keystone Symposium, 15-20 January, Santa Fe, NM, USA, p. 64. Keystone Symposia, Silverthorne, CO, USA
82. Modica-Napolitano, J. S., and Singh, K. K. 2002. Mitochondria as targets for detection and treatment of cancer. Exp. Rev. Mol. Med. 11 April, http://www.expertreviews.org/02004453h.htm
83. Modica-Napolitano, J., and Singh, K. K. 2004. Mitochondrial dysfunction in cancer. Mitochondrion 4:755-762
84. Nair, J., Barbin, A., Velic, I., and Bartsch, H. 1999. Etheno DNA-base adducts from endogenous reactive species. Mutat. Res. 424:59
85. Nelson, D. L., and Cox, M. M. 2000. Lehninger Principles of Biochemistry. Worth Publishers
86. Neumann, H. P., Pawlu, C., Peczkowaska, M., Bausch, B., McWinney, S. R., Muresan, M., Cuchta, M., Franke, G., Klisch, J., Bley, T. A., et al. 2004. Distinct clinical features of paraglioma syndromes associated with SDHB and SDHD gene mutations. J. Am. Med. Assoc. 292:943-951
87. Nishikawa, M., Oshitani, N., Matsumoto, T., Nishigami, T., Arakawa, T., Inoue, M. 2005. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br. J. Cancer 93:331-337
88. Oberley, L. W. 2001. Antioxidant enzyme levels as a function of growth state in cell culture. Antioxidants Redox Signall. 3:461-472
89. Oberley, L. W., and Buettner, G. R. 1979. Role of superoxide dismutase in cancer: A review. Cancer Res. 39:1141-1149
90. O'Gorman, E., Beutner, G., Dolder, M., Koretsky, A. P., Brdiczka, D., and Wallimann, T. 1997. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 414:253-257
91. Otto, C., Kaemmerer, U., Illert, B., Muehling, B., Pfetzer, N., Wittig, R., Voelker, H. U., Thiede, A., Coy, J. F. 2008. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer 8:122
92. Pedersen, P. L., and Morris, H. P. 1974. Uncoupler-stimulated adenosine triphosphatase activity. Deficiency in intact mitochondria from Morris hepatomas and ascites tumor cells. J. Biol. Chem. 249:3327-3334
93. Pedersen, P. L. 1978. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res. 22:190-274
94. Petit, P. X., and Kroemer, G. 1998. Mitochondrial regulation of apoptosis. In Mitochondrial DNA Mutations in Aging, Disease and Cancer (Singh, K. K., ed.), pp. 147-165. Springer-Verlag, Berlin, Germany
95. Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., Marshall, F. F., Wallace, D. C. 2005. mtDNA mutations increase tumorigenicity in prostate cancer. PNAS 102:719-724
96. Platz, E. A., and De Marzo, A. M. 2004. Epidemiology of inflammation and prostate cancer. J. Urol. 171:S36-40
97. Poderoso, J. J., Carreras, M. C., Lisdero, C., Riobo, N., Schopfer, F., and Boveris, A. 1996. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328:85-92
98. Pollard, P. J., Briere, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., Hargreaves, I. P., Heales, S. J., Chung, Y. L., Griffiths, J. R., Dalgleish, A., McGrath, J. A., Gleeson, M. J., Hodgson, S. V., Poulsom, R., Rustin, P., and Tomlinson, I. P. M. 2005. Accumulation of Krebs cycle intermediates and over-expression of HIF1 in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14:2231-2239
99. Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J. K., Markowitz, S. D., Trush, M. A., Kinzler, K. W., Vogelstein, B. 1998. Somatic mutations of the mitochondrial genome in human colorectal tumours Nat. Genet. 20:291-293
100. Powers, S. K. 1988. In Application of Lasers in Neurosurgery (Cerullo, L. J. ed.), pp. 137-155. Year Book Medical Publishers, Chicago, IL, USA
101. Pugh, C. W., and Ratcliffe, P. J. 2003. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat. Med. 9:677-684
102. Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., and Perucho, M. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967-969
103. Reed, J. C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6
104. Reed, J. C. 1997. Double identity for proteins of the Bcl-2 family. Nature 387:773-776
105. Schatz, G. 1996. The protein import system of mitochondria. J. Biol. Chem. 271:31763-31766
106. Schiemann, S., Schwirzke, M., Brunner, N, and Weidle, U. H. 1998. Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer. Clin. Exp. Metast. 16:129-139
107. Selak, M. A., Armour, S. A., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., and Gottieb, E. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-prolyl hydroxylase. Cancer Cell 7:77-85
108. Sies, H 1999. Free Radic. Biol. Med. 27:916-921
109. Simons, A. L., Ahmad, I. M., Mattson, D. M., Dornfeld, K. J., Spitz, D. R. 2007. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Cancer Res. 67:3364-3370
110. Singh, K. K. 1998. Mitochondrial DNA Mutations in Aging, Disease, and Cancer. Springer, New York, USA
111. Singh, K. K. 2004. Mitochondria damage checkpoint in apoptosis and genome stability. FEMS Yeast Res. 5:127-132
112. Singh, K. K., Ayyasamy, V., Owens, K., Koul, M. S., Vuciji, M. 2008. Mutations in mitochondrial DNA polymerase gamma associated with breast cancer. Submitted
113. Singh, K. K., Kulawiec, M., Still, I., Desouki, M. M., Geradts, J., Matsui, S. 2005. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354:140-146
114. Singh, K. K., Russell, J., Sigala, B., Zhang, Y., Williams, J., Keshav, K. F. 1999. Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene 18:6641-6646
115. -, oxidative stress, and genomic instability. Cancer Res. 66:7615-7620
116. Spelbrink, J. N., Toivonen, J. M., Hakkaart, G. A., Kurkela, J. M., Cooper, H. M., Lehtinen, S. K., Lecrenier, N., Back, J. W., Speijer, D., Foury, F., Jacobs, H. T. 2000. In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J Biol Chem. 75:24818-24828
117. Spitz, D. R., Azzam, E. I., Li, J. J., and Gius, D. 2004. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: A unifiying concept in stress response biology. Cancer Metast. 23:311-322
118. Sul, H. S., Shrago, E., Goldfarb, S., and Rose, F. 1979. Comparison of the adenine nucleotide translocase in hepatomas and rat liver mitochondria. Biochim. Biophys. Acta 551:148-155
119. Summerhayes, I. C., Lampidis, T. J., Bernal, S. D., Nadakavukaren, J. J., Nadakavukaren, K. K., Shepherd, E. L., and Chen, L. B. 1982. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Natl. Acad. Sci. USA 79:5292-5296
120. Summerhayes, I. C., Wong, D., and Chen, L. B. 1983. Effect of microtubules and intermediate filaments on mitochondrial distribution. J. Cell Sci. 61:87-105
121. Sun, A. S., and Cederbaum, A. I. 1980. Oxidoreductase activities in normal rat liver, tumor-bearing rat liver, and hepatoma HC-252. Cancer Res. 40:4677-4681
122. Sun, A. S., Sepkowitz, K., and Geller, S. A. 1981. A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma. Lab. Invest. 44:13-17
123. Suzuki, T., Spitz, D. R., Gandhi, P., Lin, H. Y., and Crawford, D. R. 2002. Mammalian resistance to oxidative stress: A comparative analysis. Gene Expression 10:179-191
124. Taanman, J. W. 1999. The mitochondrial genome: structure, transcription, translation and replication. Biochim. Biophys. Acta. 1410:103-123
125. Taylor, E. R., Hurrell, F., Shannon, R. J., Lin, T. K., Hirst, J., and Murphy, M. P. 2003. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J. Biol. Chem. 278:19603-19610
126. Tomlinson, I. P., Alam, N. A., Rowan, A. J., Barclay, E., Jaeger, E. E., Kelsell, D., Leigh, I., Gorman, P., Lamlum, H., Rahman, S., Roylance, R. R., Olpin, S., Bevan, S., Barker, K., Hearle, N., Houlston, R. S., Kiuru, M., Lehtonen, R., Karhu, A., Vilkki, S., Laiho, P., Eklund, C., Vierimaa, O., Aittomaki, K., Hietala, M., Sistonen, P., Paetau, A., Salovaara, R., Herva, R., Launonen, V., Aaltonen, L. A.; Multiple Leiomyoma Consortium. 2002. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genetics 30:406-410
127. Turrens, J. F. 1997. Superoxide production by the mitochondrial respiratory chain. Biosci. Rep. 17:3-8
128. Turrens, J. F. 2003. Mitochondrial formation of reactive oxygen species. J. Physiol. 522:335-344
129. Turrens, J. F., and Boveris, A. 1980. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191:421-424
130. Tzagoloff, A. 1982. Mitochondria. Plenum Press, New York, NY, USA
131. Venturini, I., Zeneroli, M. L., Corsi, L., Avallone, R., Farina, F., Alho, H., Baraldi, C., Ferrarese, C., Pecora, N., Frigo, M., Ardizzone, G., Arrigo, A., Pellici, R., and Baraldi, M. 1998. Upregulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. Life Sci. 63:1269-1280
132. Voet, D., Voet, J. G., and Pratt, C. W. 2002. Fundamentals of Biochemistry. John Wiley & Sons, Inc., New York
133. Wang, Y., Liu, V. W., Xue, W. C., Tsang, P. C., Cheung, A. N., Ngan, H. Y. 2005. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: A quantitative study using laser-captured microdissected tissues. Gynecol. Oncol. 98:104-110
134. Warburg, O. 1930. Metabolism of Tumors. Arnold Constable, London, UK
135. Warburg, O. 1956. On the origin of cancer cells. Science 123:309-314
136. Weinhouse, S. 1955. Oxidative metabolism of neoplastic tissue. Adv. Cancer Res. 3:269-325
137. Weisberg, E. L., Koya, K., Modica-Napolitano, J., Li, Y., Chen, L. B. 1996. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res. 56:551-555
138. Weissig, V., and Torchilin, V. P. 2001. Drug and DNA delivery to mitochondria. Adv. Drug Deliv. Rev. 49:1-2
139. Wilson, B. C., and Jeeves, W. P. 1987. In Photomedicine, Vol. 2 (Ben-Hur, E., and Rosenthal, I. eds.), pp. 127-177. CRC Press, Boca Raton, FL, USA
140. Woldegiorgis, G., and Shrago, E. 1985. Adenine nucleotide translocase activity and sensitivity to inhibitors in hepatomas. Comparison of the ADP/ATP carrier in mitochondria and in a purified reconstituted liposome system. J. Biol. Chem. 260:7585-7590
141. Yen, T. C., King, K. L., Lee, H. C., Yeh, S. H., and Wei, Y. H. 1994. Age-dependent increase of mitochondrial DNA deletions together with lipid peroxides and superoxide dismutase in human liver mitochondria. Free Radic. Biol. Med. 16:207-214
142. Yakes, F. M., and Van Houten, B. 1997. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 94:514-519
143. Zamzami, N. et al. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533-1544
144. Zhang, J., Jin, B., Li, L., Block, E. R., and Patel, J. M. 2005. Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells. Am. J. Physiol. Cell. Physiol. 288:C840-C849